Technologies
Four Technology Areas, One Specialty
Historical experience in glucose monitoring product distribution.
Blood Glucose Monitoring Systems
Meters, test strips and lancing systems, assessed on published accuracy standards, everyday usability for home users, and Hebrew-language interfaces for Israeli patients and their families.
CGM Devices and Sensors
Wearable sensors, transmitters and reader devices, including calibration-free sensor generations, with particular attention to paediatric and type 1 adoption across Israel.
Diabetes Monitoring Technologies
Companion monitoring hardware around the meter and the sensor: data capture, logging accessories and the clinical reporting clinics expect from a distributed product line.
Digital Diabetes Management Solutions
Software and connected platforms that carry readings from device to clinician, reviewed for local language support, privacy practice and regulatory documentation.
Focus Areas
Technologies We Evaluate
Beyond devices, VALOOR follows diabetes monitoring technologies and digital management solutions as focus areas for new manufacturer partnerships. We evaluate technologies; we do not offer them for sale.
Connected Monitoring
Remote and connected monitoring platforms, plus data-sharing between patient, clinic and caregiver.
Apps and Dashboards
Mobile apps and cloud dashboards, with insulin dose tracking and smart pens.
Local Interoperability
Interoperability with Israeli HMO digital health systems for smooth clinical use.
Focus: diabetes monitoring technologies only.
Seeking partnerships with international diabetes technology manufacturers.
Questions
What Manufacturers Ask
What technologies do you cover?
Four diabetes technology areas: Blood Glucose Monitoring Systems, CGM Devices and Sensors, Diabetes Monitoring Technologies, and Digital Diabetes Management Solutions. Our focus is diabetes monitoring only.
What is your current status?
There are no active distribution agreements and no stock at present. We are seeking partnerships with international diabetes technology manufacturers.
Were you active before?
Yes. VALOOR brings historical experience in glucose monitoring product distribution, which shapes how we evaluate new partners today.
When was the company founded?
VALOOR was established in 1999.
Which market do you serve?
Our primary target market is Israel. We do not place the business anywhere else.
Do you hold stock?
Not at present. Stock would follow once a distribution agreement is in place with a manufacturer.
Who handles registration?
Registration with AMAR and the Ministry of Health is part of the Israeli market entry that we discuss with each manufacturer.
How does reimbursement work?
Reimbursement in Israel depends on the product category and its regulatory status. We walk partners through the route during early conversations.
Who do I contact?
Write to yossi@valoor.co and describe your technology, its regulatory status and the markets you are exploring.